Ignite Creation Date:
2025-12-24 @ 7:44 PM
Ignite Modification Date:
2025-12-25 @ 5:22 PM
Study NCT ID:
NCT04112303
Status:
COMPLETED
Last Update Posted:
2022-04-20
First Post:
2019-09-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-16
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-25
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-30
First Submit QC Date:
None
Study First Post Date:
2019-10-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-03-23
Results First Submit QC Date:
None
Results First Post Date:
2022-04-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-23
Last Update Post Date:
2022-04-20
Last Update Post Date Type:
ACTUAL